SCHEMBL12461998

SCHEMBL12461998

COc1cccn2c(=O)c(CO)c(Nc3ccc4[nH]c(C)cc4c3)nc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.38
MAP3K11 Q16584 1/20 0.37
EGFR P00533 2/20 0.37
MAOA P21397 2/20 0.37
MAOB P27338 2/20 0.37
P2RX3 P56373 2/20 0.37
MAPT P10636 3/20 0.37
KDM4E B2RXH2 1/20 0.37
APAF1 O14727 1/20 0.37
RECQL P46063 1/20 0.37
MEN1 O00255 2/20 0.36
ALDH1A1 P00352 2/20 0.36
KMT2A Q03164 2/20 0.36
PKM P14618 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
FLT1 P17948 1/20 0.36
KDR P35968 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
IDH1 O75874 2/20 0.36
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12462221 0.88 SYK (0.40) SYKMAPTKDM4EAPAF1RECQL
SCHEMBL2166734 0.86 MEN1 (0.48) SYKEGFRMAOAMAOBMEN1
SCHEMBL12462334 0.86 EGFR (0.43) SYKEGFRMAOAMAOBP2RX3
SCHEMBL15887163 0.84 MAPT (0.41) MAPTMEN1KMT2ASMN1; SMN2NPSR1
SCHEMBL12462327 0.83 MAPT (0.40) MAPTMEN1KMT2ASMN1; SMN2NPSR1
SCHEMBL12462089 0.83 KDR (0.43) SYKEGFRMAPTMEN1KMT2A
SCHEMBL14482192 0.83 SYK (0.40) SYKEGFRMAPTMEN1KMT2A
SCHEMBL15887192 0.82 KMT2A (0.42) EGFRMAPTKDM4EMEN1ALDH1A1
SCHEMBL12462088 0.82 MAPT (0.48) MAPTKDM4EMEN1ALDH1A1KMT2A
SCHEMBL1580038 0.82 MAPT (0.40) EGFRMAPTKDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130012506-A1 ANTI-INFECTIVE PYRIDO (1,2-A) PYRIMIDINES NO ZAESUNG (KR) 2013-01-10 US disclosed
US-20130012506-A1 ANTI-INFECTIVE PYRIDO (1,2-A) PYRIMIDINES NO ZAESUNG (KR) 2013-01-10 US disclosed
US-20130012506-A1 ANTI-INFECTIVE PYRIDO (1,2-A) PYRIMIDINES NO ZAESUNG (KR) 2013-01-10 US disclosed
WO-2011085990-A1 ANTI - INFECTIVE PYRIDO (1,2 -A) PYRIMIDINES INSTITUT PASTEUR KOREA (KR) 2011-07-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130012506-A1 ANTI-INFECTIVE PYRIDO (1,2-A) PYRIMIDINES TYMS, TYMP, DCTPP1 SYK 2095/4885MAP3K11 1979/4885EGFR 4171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.